miR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses by Siddhika Pareek et al.
JOURNAL OF 
NEUROINFLAMMATION
Pareek et al. Journal of Neuroinflammation 2014, 11:97
http://www.jneuroinflammation.com/content/11/1/97RESEARCH Open AccessmiR-155 induction in microglial cells suppresses
Japanese encephalitis virus replication and
negatively modulates innate immune responses
Siddhika Pareek, Saugata Roy, Bharti Kumari, Pratistha Jain, Arup Banerjee* and Sudhanshu Vrati*Abstract
Background: Microglial cells, which are resident macrophages of the central nervous system, play important roles
in immune responses and pathogenesis. Japanese encephalitis virus (JEV) is a neurotropic virus that infects
microglial cells in brain. Several microRNAs including miR-155 and miR-146a play an important role in defining the
microglia inflammatory profile. In this study, we have investigated the effect of miR-155 and miR-146a modulation
on JEV infection as well as innate immune responses in human microglial cells.
Methods: In vitro studies were performed in JEV-infected human microglial CHME3 cells. miR-155 or miR-146a were
overexpressed and total RNA and protein were extracted following JEV-infection. Expression of genes involved in
innate immune responses was studied by PCR array, quantitative real-time PCR (qPCR), western blot and
Fluorescence activated cell sorter (FACS). JEV replication was monitored by studying the viral RNA by qPCR, protein
by western blot, and titres by plaque assay.
Results: Overexpression of miR-155 in CHME3 cells resulted in significantly reduced JEV replication whereas miR-146a
overexpression had an insignificant effect. Additionally, interferon regulatory factor 8 (IRF8) and complement factor H
(CFH) were induced during JEV infection; however, this induction was attenuated in miR-155 overexpressing cells
following JEV infection. Further, JEV-induced NF-κB regulated downstream gene expression was attenuated. Interestingly,
an increased level of CD45, a negative regulator of microglia activation and a reduced phosphorylated-Signal
Transducers and Activators of Transcription (p-STAT1) expression was observed in miR-155 overexpressing cells upon
JEV infection.
Conclusion: Induction of miR-155 in human microglial cells may negatively modulate JEV-induced innate immune
gene expression and may have a beneficial role in limiting JEV replication in human microglial cells.
Keywords: NeurimmiRs, JEV, CD45, Microglia activationBackground
Japanese encephalitis (JE) is an acute central nervous
system (CNS) inflammatory disease caused by infection
with Japanese encephalitis virus (JEV); a small, envel-
oped, plus-strand RNA virus belonging to the Flaviviri-
dae family. It is the leading cause of viral encephalitis in
south-east Asia, India, and China where three billion
people are at risk of contracting the disease, yet its
pathogenesis remains poorly understood. While neurons* Correspondence: banerjeea@thsti.res.in; vrati@thsti.res.in
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unless otherwise stated.are believed to be the primary target of JEV in the brain,
a recent report has suggested that microglial cells can be
directly infected with JEV [1,2]. Microglial cells are the
resident immune cells of the CNS and have a critical
role in host defense against invading pathogens. However,
substantial evidence suggests that infection of microglia
by JEV may actually lead to neuronal cell death through
uncontrolled production of pro-inflammatory cytokines.
Therefore, downregulation of cytokine production can
serve to dampen the inflammatory response and can con-
tribute to better virus clearance and increased protection
against JEV [3]. Indeed, inhibition of chronic neuroinflam-
mation, particularly due to microglial activation, has beenLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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neurodegenerative diseases [4,5].
Recently, a new class of regulatory RNAs, called
microRNAs (miRNAs) have emerged that modulate
immune response and play key regulatory roles in virus-
host interactions. These miRNAs serve as universal reg-
ulators of differentiation, activation, and polarization of
mammalian cells including microglia and macrophages
in normal and diseased CNS [6]. Thus, modulation of
cellular miRNA expression during viral infection may be
an important determinant of disease outcome [7]. Re-
cent reports suggested that a subset of miRNAs, termed
as NeurimmiRs, co-exist in the brain and peripheral or-
gans [8,9]. These miRNAs can affect both neuronal and
immune functions and thus constitute important thera-
peutic targets for those diseases that affect both the
immune system and brain functions. Among them,
miR-155 and miR-146a are multifunctional and widely
reported to modulate different stages of innate immune
response during inflammation and infection [10-12].
Thus, miR-155 and miR-146a were shown to increase in
the microglial cells in response to stimulation with Lipo-
polysaccharides (LPS) and Polyinosinic-polycytidylic acid
(poly(I:C), respectively, and they seem to play a funda-
mental role in the microglial inflammatory profile
[13,14]. These miRNAs are also associated with inter-
feron (IFN) signaling pathways [15,16]. Moreover, miR-
155 and miR-146a not only modulate Toll-like receptors
(TLRs)-mediated innate immune response, but also tar-
get complement regulatory proteins and facilitate com-
plement activation [17-19]. This phenomenon is very
important to eliminate the virus from infected cells. Fur-
thermore, both miR-146a and miR-155 have been shown
to play an important role in viral infection. For example,
Wu et al. [20] reported an increased dengue virus 2
(DENV2) replication in miR-146a overexpressing cells,
whereas overexpression of miR-155 significantly sup-
pressed human immunodeficiency virus (HIV) infection
in activated macrophages [21].
Since JEV is a neurotropic virus it is likely that Neur-
immiRs play an important role in virus replication and
immunopathology. Using a global miRNA array we have
identified differentially expressed NeurimmiRs in human
microglial cells during the course of JEV infection. Of
these, we have focused our study on miR-155 and
miR-146a and have investigated their effect on JEV repli-
cation and their role in the modulation of microglia-
mediated innate immune response during JEV infection.
For this purpose, in vitro studies were performed in
JEV-infected human microglial CHME3 cells. Our re-
sults indicate that miR-155 induction might have a
beneficial role for the host by limiting JEV replication
through modulation of microglia-mediated innate im-
mune responses.Materials and methods
Cells, antibodies, miRNA mimics, and inhibitors
Human microglial cells (CHME3) were provided by the
National Brain Research Centre, Manesar, India. Porcine
stable kidney (PS) cell line was procured from National
Centre for Cell Science, Pune, India. CHME3 cells were
grown in Dulbecco’s Modified Eagle’s Medium (DMEM,
Invitrogen, Carlsbad, CA, USA) and PS cells in Eagle’s
Minimal Essential Medium (MEM, Invitrogen, Carlsbad,
CA, USA) supplemented with 10% fetal bovine serum
(FBS), 2 mM L-glutamine, and 100 μg/ml penicillin-
streptomycin (Invitrogen, Carlsbad, CA, USA). Primary
antibodies against MyD88, Ikkε, IRF8, p-STAT1, STAT1
and HRP-conjugated secondary antibodies were pur-
chased from Cell Signaling Technology, Beverly, MA,
USA. CD-45 antibodies were from BD Biosciences, San
jose, CA, USA. Rabbit antibody against JEV NS1 protein
was produced in-house. MicroRNA mimics and inhibi-
tors were from Invitrogen, Carlsbad, CA, USA (Assay
ID: MC12601, mimic for hsa-miR-155-5p; MH12601, in-
hibitor for hsa-miR-155-5p; MC10722, mimic for hsa-
miR-146a-5p; MH10722, inhibitor for hsa-miR-146a-5p,
mirVana® miRNA Mimic Control #1). NF-κB inhibitor
ammonium pyrrolidine dithiocarbamate, and PI3K in-
hibitor LY294002 were from Sigma-Aldrich, Saint Louis,
MO, USA.
Transfection of cells and virus infection
The P20778 strain of JEV was propagated in PS cells
and titrated by plaque assay [22]. Microglial cells were
seeded in 6-well tissue culture plates at a density of
0.5 × 106 cells/well and transfected 24 hours later using
Lipofectamine 2000® reagent (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s protocol. For over-
expression or inhibition studies, 25 pmol of a miRNA
mimic or inhibitor, respectively, was transfected. Cells
were washed with 1 × PBS after 24 hours transfection and
infected with JEV at multiplicity of infection 5 (MOI = 5).
Culture supernatant was collected for virus titration as
plaque forming unit (PFU)/ml and cells lysate was used
for protein and RNA studies at different times post-
infection (pi).
RT2 Profiler PCR array
The Human NFκB Signaling Targets PCR array (#PAHS-
0225Z) (SA Biosciences/Qiagen, Hilden, Germany) was
used to determine the profile of genes associated with
the human innate and adaptive immune responses. Total
RNA was extracted from JEV-infected and uninfected or
specific mimic- and inhibitor-transfected CHME3 cells
using RNeasy mini kit (Qiagen, Hilden, Germany) with
inclusion of a DNase I treatment step. cDNA was pre-
pared from 1 μg total RNA using a RT2 PCR array first
strand kit (Qiagen, Hilden, Germany). Quantitative real-
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7500 (Applied Biosystems, Foster City, CA, USA) ac-
cording to the manufacturer’s instructions.
Western blot analysis
Control and treated microglial cells were washed with
1 × PBS and lysed in cell lysis buffer (Sigma-Aldrich,
Saint Louis, MO, USA) in the presence of protease in-
hibitor cocktail (Roche Diagnostics, Basel, Switzerland).
The concentration of the protein lysate was determined
using the Bradford method. The protein sample (50 μg)
was electrophoresed on 10% sodium dodecyl sulfate-
polyacrylamide gel (SDS-PAGE) and transferred onto a
nitrocellulose membrane. The membrane was then
blocked using 5% non-fat dry milk in PBST (PBS con-
taining 0.05% Tween-20) for one hour at room tem-
perature on a shaker. After blocking, the membrane was
incubated with rabbit anti-human primary antibody
overnight at 4°C with gentle shaking. After three washes
of 10 minutes each with 1 × PBST, blots were incubated
with anti-rabbit horseradish peroxidase (HRP) conju-
gated secondary antibody for one hour with gentle shak-
ing at room temperature. After three washes of the
membrane for 10 minutes each with PBST the western
blots were developed using chemiluminescence reagents
(Santa Cruz Biotechnology, Dallas, Texas, USA). After-
wards membranes were stripped using stripping buffer
(10% SDS, Tris-Cl pH-6.8, 0.8% β-mercaptoethanol) and
re-probed with Glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) antibodies. The protein levels were
normalized with the GAPDH levels.
Flow cytometry assay
Expression of CD-45 isoforms on CHME3 cells was exam-
ined by fluorescence activated cell sorter (FACS) analysis.
Cells were fixed using 2% para-formaldehyde and stained
with CD-45 antibody conjugated with Alexa-488 dye (BD
Biosciences, San jose, CA, USA) as per the manufacturer’s
instruction. Samples were analyzed on FACS Calibur cell
analyser (BD Biosciences, San jose, CA, USA). Data were
analyzed using FlowJo flow cytometry analysis software
(Tree Star Inc, Ashland, OR, USA).
Quantitation of mRNA expression
Cells were lysed in TRIzol reagent (Invitrogen, Carlsbad,
CA, USA) for RNA isolation and the total RNA was iso-
lated using RNeasy kit (Qiagen, Hilden, Germany). RNA
concentration was quantified using a NanoDrop 2000
spectrophotometer (Thermo Fisher, Waltham, MA, USA).
RNA (1 μg) was reverse transcribed using prime script
first-strand cDNA Synthesis kit (Takara Bio Inc. Otsu,
Shiga, Japan) in a 20 μl reaction according to the manufac-
turer’s protocol. The expression of cellular genes was stud-
ied by qPCR with the fluorescent DNA-binding dye SYBRgreen (Power SYBR Green PCR master kit; Applied Bio-
systems, Foster City, CA, USA) by the real-time fluores-
cence detection method. JEV RNA was quantified as
described earlier [23]. Each quantitative PCR reaction was
performed in triplicate and the mean threshold cycle (Ct)
value for each sample was used for data analysis. The
RNA transcript levels were normalized to that of GAPDH.
Quantitation of miRNA expression
For detection of mature miRNAs, 10 ng total RNA was
reverse transcribed in vitro to cDNA using the TaqMan
MicroRNA Reverse Transcription kit (Applied Biosystems,
Foster City, CA, USA) according to the manufacturer’s
instructions. All miRNAs were assayed individually by
TaqMan probe-directed real-time PCR (Reporter-FAM,
Quencher-NFQ-MGB, Applied Biosystems, Foster City,
CA, USA) using ABI 7500 Fast Real-Time PCR system
(Applied Biosystems, Foster City, CA, USA). The follow-
ing thermal cycling profile was used for the PCR analysis:
95°C for 15 minutes, 40 cycles at 94°C for 15 seconds, and
55°C for 30 seconds. Each qPCR reaction was performed
in triplicate and the mean Ct value for each sample was
used for data analysis. Expression levels of miRNAs were
normalized to that of U6 snRNA.
Statistical analysis
All experiments were performed in triplicate. Gene expres-
sion profiling data were analyzed statistically using one-
way analysis of variance (ANOVA) following Bonferroni’s
multiple comparison tests. Data were presented as the
mean ± SD; statistical significance of difference (P value)
for two means was assessed using an unpaired Student’s
t-test using the GraphPad Prism 5 software (GraphPad,
San Diego, CA, USA), and P < 0.05 was considered
significant.
Results
JEV infection modulates expression of NeurimmiRs in
microglial cells
In order to understand how JEV infection modulates im-
mune pathogenesis-related miRNAs, we carried out a
global human miRNA array study to identify differen-
tially expressed miRNAs in human microglial CHME3
cells in response to JEV infection. Of the several miR-
NAs modulated during the course of infection, we fo-
cused here on a subset of seven miRNAs that have
previously been defined as NeurimmiRs [8,9]. Following
the bioinformatics and statistical analysis, we found that
six of these NeurimmiRs were differentially expressed in
CHME3 cells during JEV infection (Figure 1A). We ob-
served that miR-125b and miR-132 remained down-
regulated throughout the course of infection. While
miR-146a and miR-326 were up-regulated at an early
time point (6 hours pi), these were down-regulated as
Figure 1 Differential expression of NeurimmiRs in human microglial cells after JEV infection. CHME3 cells were mock-infected or infected
with JEV. Total RNA was isolated from cells at different time points. (A) Relative abundance of six NeurimmiRs obtained from human miRNA
microarray was shown as log2 fold-change. (B) Levels of miR-155 and miR-146a were determined by qPCR and plotted as relative to that seen in
the mock-infected cells. Data were normalized against U6 snRNA. h, hours; JEV, Japanese encephalitis virus; pi, post-infection. *, P <0.05; **, P <0.005.
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and miR-155 were suppressed at early time points, but
were up-regulated at later time points. No change was
seen in miR-212 levels during JEV infection.
As this study focused on miR146a and miR-155 we
validated their expression in human microglial cells by
qPCR using the TaqMan assay. The qPCR data generally
conformed to the microarray data. Thus, miR-146a ex-
pression levels showed a small increase at 6 hours pi
followed by a reduction at 24 hours pi. For miR-155
however, the expression levels showed a small decrease
at 6 hours pi that was followed by a moderate (approxi-
mately 1.8-fold) increase at 48 hours pi (Figure 1B).
miR-155 suppresses JEV replication in microglial cells
In order to understand the effect of miR-155 and miR-
146a modulation on JEV replication, we overexpressed
these miRNAs in microglial cells by transfecting specificFigure 2 JEV replication in human microglial cells. CHME3 cells were tra
(M-146a) followed by JEV infection. Virus replication was monitored at 24 hou
(B) Relative levels of JEV RNA were quantified by qPCR. Data were normalized
determined by plaque assay. GAPDH, Glyceraldehyde 3-phosphate dehydroge
**, P <0.005.mimics and infected the cells with JEV. At 24 hours pi,
levels of the JEV NS1 protein and JEV RNA were signifi-
cantly reduced in miR-155 overexpressing microglial
cells, but these were largely unaffected in miR-146a
overexpressing cells (Figure 2A and B). A significant
suppression of JEV titres (approximately 1 log2) was ob-
served in miR-155 overexpressing cells while miR-146a
overexpression had no effect on JEV titre (Figure 2C).
These data clearly show that miR-155 had an inhibitory
effect on JEV replication in microglial cells.
miR-155 modulates JEV-induced IFN-β expression in
microglial cells
The innate immune response involving the induction of
type I IFN constitutes the first line of antiviral defenses
and could contribute to reduced virus replication. Since
miR-155 and miR-146a are known to modulate IFN-β
expression in peripheral organs [15,16], we focused onnsfected with control mimic (CM), mimic-155 (M-155) and mimic-146a
rs pi. (A) JEV NS1 expression was studied using western blotting.
against GAPDH RNA. (C) JEV titres in culture supernatants were
nase; JEV, Japanese encephalitis virus; pi, post-infection. *, P <0.05;
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JEV-infected microglial cells. For this, we overexpressed
these miRNAs in CHME3 cells by transfecting specific
mimic (mimic-155 or mimic-146a) 24 hours prior to
JEV infection. Our data showed that JEV-induced IFN-β
mRNA expression in CHME3 cells and the levels of this
JEV-induced IFN-β mRNA were significantly reduced in
miR-155 overexpressing cells, while only a marginal ef-
fect was observed in miR-146a overexpressing cells
(Figure 3A). In fact, the suppressive effect of miR-155 on
IFN-β mRNA expression was reversed when the miR-
155 inhibitor was used. Thus cells transfected with the
miR-155 inhibitor prior to JEV infection showed an en-
hanced IFN-β mRNA expression when compared to con-
trol mimic-transfected cells infected with JEV (Figure 3A).
Infection of mammalian cells by viruses leads to ex-
pression of interferon-stimulated genes (ISG) [24]. We
have studied the effect of miR-155 and miR-146a overex-
pression on ISG expression in JEV-infected microglial
cells. Figure 3B shows that JEV-induced ISG expression
was significantly repressed in miR-155 overexpressing
cells, whereas it was only marginally affected in miR-
146a overexpressing cells. The suppressive effect of
miR-155 overexpression on IFIT1 expression could be
decreased by the miR-155 inhibitor (Figure 3C). These
data indicate that JEV infection of miR-155 overexpress-
ing microglial cells resulted in a reduced expression of
IFN-β and ISG.
miR-155 attenuates JEV-induced IRF8 expression in
microglial cells
The interferon regulatory factor (IRF) family of tran-
scription factors regulate the entire type I IFN system.
IRF8, a member of IRF family, is a myeloid lineage tran-
scriptional regulator that plays an essential role in theFigure 3 JEV-induced IFN-β mRNA expression in human microglial ce
and mock-infected or infected with JEV 24 hours later. Total RNA was extra
qPCR normalized against those of GAPDH. (A) Relative IFNβ mRNA expressi
abundance of various ISG transcripts in JEV-infected cells compared to moc
transfected cells compared to CM transfected cells following JEV infection. CM
I-155, h, hours; inhibitor 155; IFN, interferon; ISG, interferon-stimulated genes; J
pi, post-infection. **, P <0.005.microglial activation and is involved in inducing innate
immune response. IRF8 and IRF3 can cooperatively in-
duce rapid IFN-β production in monocytes [25]. It is
also reported that TLR receptor signaling can activate
NF-κB through IRF8 in myeloid lineage cells [26]. We
therefore, studied IRF3 and IRF8 expression in human
microglial cells during JEV infection. Our results sug-
gested that IRF8 was induced during JEV infection and
significantly up-regulated mRNA levels were observed at
48 hours pi. However, there was relatively little increase
in IRF3 expression during JEV infection (Figure 4A, left
panel). Western blot results corroborated this finding
where enhanced IRF8 protein levels were seen in JEV-
infected cells at 48 hours pi (Figure 4A, right panel).
Interestingly, JEV-induced IRF8 expression was sup-
pressed in miR-155 overexpressing cells and this could
be reversed using the miR-155 inhibitor (Figure 4B, left
panel). Importantly, expression of IRF8 was not affected
in miR146a overexpressing cells (Figure 4B, right panel).
These data demonstrate that miR-155 can suppress JEV-
induced IRF8 expression and this might result in the re-
duced IFN-ß levels seen above.
miR-155 attenuates JEV-induced NF-κB pathway gene
expression in microglial cells
NF-κB-mediated pro-inflammatory gene expression plays
an important role in innate immune response against viral
infection. Figure 5A shows that NF-κB activation is re-
quired for IFN-β induction in JEV-infected cells as inhib-
ition of NF-κB activity led to reduced IFN-β mRNA
expression in human microglial cells. Since JEV-induced
IFN-β expression was suppressed in miR-155 overexpress-
ing cells (Figure 3A), we hypothesized that miR-155 might
attenuate JEV-induced innate immune gene expression. In
order to identify the innate immune genes that arells. CHME3 cells were transfected with CM, M-155, M-146a, or I-155
cted 24 hours pi. and levels of various transcripts were determined by
on in JEV-infected cells compared to mock-infected cells. (B) Relative
k-infected cells. (C) Relative expression of IFIT1 in M-155 and I-155
, control mimic; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase;
EV, Japanese encephalitis virus; M-146a, mimic 146a; M-155, mimic 155;
Figure 4 JEV-induced IRF8 expression in human microglial cells. (A) CHME3 cells were mock-infected or infected with JEV and total RNA
was extracted from cells harvested at different time points. Relative levels of IRF8 and IRF3 transcripts in JEV-infected cells compared to those in
mock-infected cells are presented in the left panel. GAPDH expression was used to normalize the data. The right panel shows IRF8 protein levels
during JEV infection. (B) CHME3 cells were transfected with CM, M-155 and I-155 followed by JEV infection. The left panel shows the relative
abundance of IRF8 measured by qPCR in JEV infected cells in comparison to that in mock-infected cells. GAPDH expression was used to normalize
the data. The right panel shows the western blot of IRF8. CM, control mimic; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; h, hours;
I-146a, inhibitor 146a; I-155, inhibitor 155; IRF, interferon regulatory factor; JEV, Japanese encephalitis virus; M-146a, mimic 146a; M-155, mimic 155;
pi, post-infection. *, P <0.05.
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was performed covering 84 genes directly or indirectly
regulated via the NF-κB pathway. The heat map shown in
Figure 5B, depicts dysregulated genes in CHME3 cells
during JEV infection. Cells transfected with the control
mimic followed by JEV infection had 26 genes up-
regulated (over 2-fold). On the other hand, 32 genes were
up-regulated in miR-155 overexpressing cells infected
with JEV. Interestingly, 19 of these up-regulated genes
were common in both sets. However, 16 out of these 19
genes exhibited attenuation of their expression in miR-
155 overexpressing JEV-infected cells (Figure 5C). We
studied the expression of several of these mRNAs by
qPCR (Figure 5D). IL-12B and IL-4 are anti-inflammatory
genes and the expression of these was up-regulated
whereas PTGS2 (COX2), an inflammatory mediator, was
significantly suppressed in miR-155 overexpressing cells.
CCR-5, which has an important role in JEV infection, [27]
was up-regulated in these cells. These qPCR data con-
formed to the PCR array data.
Interestingly, miR-155 and miR-146a are reported to
be involved in the reduction of NF-κB activity by target-
ing specific genes (Ikkε, MyD88, TAB2, TRAF6, IRAK1)
in the TLR-mediated NF-κB activating pathways [15,28].PCR array data showed that JEV-induced MyD88 mRNA
expression was suppressed in miR-155 overexpressing
cells. The reduced MyD88 protein level was confirmed
by western blot. However, Ikkε protein levels were not
affected (Figure 5E). As observed in the PCR array, IL-6
mRNA expression was markedly reduced in M-155 over-
expressing cells following JEV infection. Transcription
factor C/EBPβ, which activates IL-6 gene expression, is
among the potential direct mRNA targets of miR-155.
TGF-ß activated kinase 1/MAP3K7 binding protein 2
(TAB2) is another important multifunctional molecule
that activates NF-κB. Our results showed that both C/
EBPβ and TAB2 mRNA expression were significantly at-
tenuated in miR-155 overexpressing cells following JEV
infection (Figure 5F). These results indicate that miR-
155 can differentially target multiple genes in the NF-κB
signaling pathway, resulting in significant modulation of
the expression of innate immune genes in JEV-infected
human microglial cells.
miR-155 enhances JEV-induced CD45 expression on
microglial cells
Following an infection or an injury, resting microglial
cells could polarize into two major activated subtypes
Figure 5 JEV-induced NF-κB targeted gene expression in human microglial cells. (A) CHME3 cells were treated for 6 hours with NF-κB
inhibitor (25 μM) or PI3K inhibitor (10 μM) using DMSO as a vehicle. This was followed by JEV infection for 24 hours. Total RNA was extracted and
relative IFN-β mRNA expression was measured using qPCR in inhibitor-treated cells compared to the vehicle-treated cells. GAPDH was used to
normalize the data. (B) CHME3 cells were transfected with CM, M-155 or M-146a and infected with JEV 24 hours later. Total RNA was extracted
24 hours pi and levels of various NF-κB targeted genes were studied using PCR array. Hierarchical clustering represents the co-regulated genes
across the groups. Relative gene expression levels were depicted according to the colour scale (green - downregulation, red - upregulation). Gene
designations are listed to the left. (C) Expression of NF-κB targeted genes expression that were found to be common (n = 19) in PCR array among
three different groups (CM + JEV, M-146a + JEV, and M-155 + JEV) in CHME3 cells. An attenuated expression of JEV-induced genes was observed in
miR-155 overexpressing cells. (D) Expression of IL-12B, PTGS-2, CCR5 and IL-4 was studied by qPCR. The figure shows a relative abundance of
transcripts in JEV-infected, mimic-transfected CHME3 cells when compared with those in cells transfected with the mimics. GAPDH was used to
normalize the data. (E) Expression of MyD88 and Ikkε in miR-155 or miR-146a overexpressing JEV-infected CHME3 cells as seen by western
blotting. (F) Expression of different mRNAs in miR-155 overexpressing CHME3 cells following infection with JEV. CM, control mimic; DMSO,
Dimethyl sulfoxide; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; IFN, interferon; JEV, Japanese encephalitis virus; M-146a, mimic 146a;
M-155, mimic 155.
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duces pro-inflammatory cytokines and promotes cell-
mediated immunity, whereas M2 microglia tends to
dampen inflammation and clear cellular debris [29]. In
this context CD45, a hematopoietic cell-specific protein
tyrosine phosphatase, acts as a negative regulator of
cytokine receptor signaling leading to altered microglial
activation [29-31]. We observed that JEV infection inmiR-155 overexpressing human microglial cells up-
regulated CD45 expression on cell surface (Figure 6A).
As a downstream effect of this modulation, we have
checked p-STAT1 expression (which is important in pro-
inflammatory cytokine production) as well as the expres-
sion of ISG. We observed that JEV infection in the
control mimic or miR-146a overexpressing cells led to
enhanced p-STAT1 expression. On the other hand,
Figure 6 JEV-induced CD45 expressions in human microglial cells. (A) CHME3 cells were transfected with CM, M-155 or I-155 followed by
JEV infection for 24 hours. Cells were harvested and examined for CD45 expression by FACS. Data were analyzed by FlowJo software (Tree Star).
Y-axis represents the number of events normalized according to FlowJo algorithms. (B) p-STAT1 and STAT1 expression was studied in JEV-infected
cells by western blotting. (C) Relative expression of TNF-α, IL-1β, IL-4 and IL10 mRNA in M-155 transfected cells infected with JEV when compared with
those transfected with CM. The data were normalized against GAPDH. CM, control mimic; FACS, fluorescence activated cell sorter; GAPDH,
Glyceraldehyde 3-phosphate dehydrogenase; I-155, inhibitor 155; JEV, Japanese encephalitis virus; M-146a, mimic 146a; M-155, mimic 155.
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overexpressing cells infected with JEV (Figure 6B). We
have also examined the mRNA expression of other
cytokine genes by qPCR. Thus, IL-1β, TNF-α, and IL-10
expression was significantly reduced in miR-155 over-
expressing JEV-infected cells, but IL-4 levels were not af-
fected (Figure 6C). Together, these data show that
overexpression of miR-155 during JEV infection en-
hances CD45 expression on the microglial cell surface
and negatively modulates cytokine expression.
miR-155 suppresses JEV-induced complement factor H
expression in microglial cells
Complement factor H (CFH) is a central regulator of the
complement system and viruses could up-regulate CFH
expression to inhibit excessive complement activation
against them. CFH expression can be regulated by miR-
155 or miR-146 as both of them have matched seed se-
quences on the 3’-untranslated region (UTR) of the CFH
gene [17,18]. In this study, we examined the expression
of CFH and other complement pathway regulators inmicroglial cells following JEV infection. We found that
CFH mRNA expression was significantly enhanced at
48 hours pi (Figure 7A, left panel). Expression of other
complement regulators (CD46, CD55, or CD59) showed
a marginal increase during the early phase of JEV infec-
tion (6 hours pi) but at the later time points it was same
as in uninfected control cells (Figure 7A, right panel).
Moreover, JEV-induced CFH expression was NF-κB
dependent as NF-κB inhibition prior to JEV infection did
not enhance CFH expression (Figure 7B). Further, over-
expression of miR-155, but not miR-146a, attenuated the
CFH expression in microglial cells during JEV infection
(Figure 7C).
Discussion
Microglia plays key roles in both innate and adaptive im-
mune response in the CNS. In the mammalian immune
system miRNAs control differentiation as well as innate
and adaptive immune responses. A subset of these miR-
NAs (designated NeurimmiRs) notably affects both im-
mune and neuronal functions. In this study, we have
Figure 7 JEV-induced CFH expression in human microglial cells. (A) CHME3 cells were mock-infected or infected with JEV. Total RNA was
extracted from cells at different time points. The relative mRNA levels of CFH (left panel) and CD59, CD55, and CD46 (right panel) were determined
in JEV-infected cells using qPCR in comparison to that in mock-infected cells. GAPDH was used as the normalizing control. (B) CHME3 cells were
treated with either DMSO as a vehicle, NF-κB (25 μM) or PI3K inhibitor (10 μM) in DMSO for 6 hours followed by JEV infection for 24 hours. Total
RNA was extracted and relative levels of CFH expression was studied by qPCR in different treatments when compared with vehicle-treated cells.
(C) CHME3 was transfected with CM, M-155 or M-146a. After 24 hours of transfection cells were either mock-infected or infected with JEV for
another 24 hours. Total RNA was extracted and relative levels of CFH mRNA determined in JEV-infected cells in comparison to those seen in
mock-infected cells. CFH, complement factor H; CM, control mimic; DMSO, Dimethyl sulfoxide; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase;
h, hours; JEV, Japanese encephalitis virus; M-146a, mimic 146a; M-155, mimic 155; pi, post-infection. *, P <0.05; **, P <0.005.
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and have studied their role in JEV replication and micro-
glial activation during the infection. These two miRNAs
are widely reported to have an immense effect on innate
immune response in the context of various external
stimuli (such as TLR ligands, virus, bacteria, and other
microorganisms). However, very little is known about
their role in innate immune modulation during neuro-
tropic flavivirus infection. Here, we have used cultured
human microglial cells to understand the effect of JEV
infection on these two miRNAs. We have also studied
how overexpression of these two miRNAs in microglial
cells could affect JEV replication and how these miRNAs
could modulate innate immune responses as well as
microglial activation. We observed that the expression
of miR-155 was enhanced in microglial cells during JEV
infection. This may be due to the fact that miR-155production is transiently under the control of NF-κB
which is activated during JEV infection and inflamma-
tion [28,32]. Since both these miRNAs are known to
have a role in antiviral immunity, we hypothesized that
upregulation of these miRNAs might play a role in con-
trolling JEV infection. Interestingly, we found that JEV
replication was significantly restricted in miR-155 over-
expressing cells.
To gain an insight into the mechanism of how miR-
155 overexpression suppressed JEV replication, we ana-
lyzed JEV genomic RNA in silico with miRNA target
prediction algorithms (PITA and RNA22) but found no
potential target sites for miR-155. Hence, miR-155 is un-
likely to target JEV RNA directly. We next examined
IFN-β in JEV-infected miRNAs overexpressing cells as
inducible miR-155 in response to the vesicular stomatitis
virus (an RNA virus) infection in macrophage was
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replication [16]. However, to our surprise we found sig-
nificant reduction in JEV-induced IFN-β as well as
downstream ISG mRNA expression in cells where miR-
155 was overexpressed. This suggests that miR-155 uses
different mechanisms to exert an antiviral effect against
JEV in microglial cells. In fact, Swaminathan et al. [21]
have shown that miR-155 exerts an anti-HIV-1 effect by
targeting several HIV-1 dependency factors involved in
post-entry, pre-integration events, leading to severely di-
minished HIV-1 infection. Thus, miR-155 can use differ-
ent mechanisms for its antiviral effect depending upon
the virus and the environmental stimuli generated dur-
ing the particular virus infection of a certain cell type.
In order to understand reduced IFN-β expression in
JEV-infected miR-155 overexpressing cells, we checked
the expression of IRFs. Among the several IRFs reported,
we focused our study on IRF8 as it plays a major role in
IFN signaling, response to infection, and maturation of
myeloid lineages cells [33]. IRF8 is also involved in the
rapid induction of IFN-β in human monocytes [25].
Moreover, IRF8 may activate a program of gene expres-
sion that transforms microglia into a reactive phenotype
[34]. In this study, we observed that JEV infection in
microglia can induce IRF8 expression, but the same ex-
pression was attenuated in miR-155 overexpressing cells
and may be a possible reason for reduced IFN-β produc-
tion in miR-155 overexpressing cells. Interestingly, bio-
informatics analysis predicted IRF8 as one of the
potential targets for miR-155. We cloned 3’-UTR of
IRF8 in the luciferase reporter system for miRNA target
validation but found no change in the luciferase readout
in miR-155 overexpressing cells (data not shown). We
have shown that IRF8 is induced during JEV infection.
Since JEV replication and titres are reduced in miR-155
overexpressing cells, it could result in reduced IRF8
induction.
IRF8 is also involved in TLR-mediated NF-κB activa-
tion [26]. Since JEV-induced IRF8 expression in miR-155
overexpressing cells was attenuated, we sought to under-
stand its effect on NF-κB pathway. For this we examined
84 genes by RT-PCR array whose expression and func-
tion, either directly or indirectly, depend on NF-κB
activation. We found several genes, including IFN-β,
MyD88, STAT1, PTGS2, and IL-12B, which are induced
by JEV and show attenuated expression in miR-155 over-
expressing cells. Recently, CCR5 receptor expression in a
mouse model of JE was reported to play an important
role in recovery as well as promote host survival against
JEV [27]. Interestingly, increased CCR5 expression was
also observed in our cell culture based study. Thus,
modulation of NF-κB mediated signaling pathway genes
by JEV-induced miR-155 expression might play a role in
reduced JEV replication in microglial cells.Specific induction of active SHP2 phosphatase dephos-
phorylates IRF8, which in turn becomes an active repres-
sor and down-regulates TLR-mediated gene expression
[35]. In hematopoietic cell lineage CD45 (a Src-homology
2 domain (SH2)-containing protein tyrosine phosphatase)
plays an important role in regulating cytokine receptor
mediated signal [36]. Analysis of microglia ex vivo revealed
that IRF8-deficient microglia had significantly increased
levels of CD45 [37]. Thus attenuated IRF8 expression in
miR-155 overexpressing cells may result in enhanced
CD45 expression on microglial cells.
Following an infection, resting microglial cells can get
activated into M1 or M2 phenotypes. The M1 phenotype
is a pro-inflammatory state and induces neuropathology,
whereas M2 is anti-inflammatory state that could have a
neuroprotective role [36]. It is reported that CD45 can
negatively regulate CD40L-CD40-induced microglial M1
activation; an effect leading to the promotion of the M2
phenotype. Moreover, this CD45-mediated activation
state appears to decrease harmful cytokine production
[36]. In this study, we observed an increased CD45 ex-
pression in JEV-infected miR-155 overexpressing cells
and relatively reduced p-STAT1 expression. Further,
mRNA expression for pro-inflammatory cytokines IL-1β
and TNF-α was reduced in miR-155 overexpressing cells.
CD45 has also been shown to down-regulate NF-κB, an
important mediator of pro-inflammatory cytokines [38].
Thus, increased CD45 expression in JEV-induced miR-
155 expressing cells may explain reduced expression of
NF-κB pathway genes in our study. Taken together, these
data show that miR-155 induction can modulate the
JEV-induced microglial activation to a state that may be
beneficial to the host. Further in vivo study is needed to
clarify this issue.
Complement activation is considered to be an important
component of innate immune response against invading
pathogens. CFH is one of the regulators which negatively
regulate the complement activation. Viruses can utilize
CFH to evade the innate immune response. The non-
structural protein NS1 of the West Nile virus, a flavivirus,
inhibits complement activation by binding to CFH [39].
CFH can be induced by NF-κB activation and can be regu-
lated through miRNAs [17]. Interestingly, both miR-155
and miR-146a have the same target sequence in the 3’-
UTR of CFH and this has been experimentally proven for
both the miRNAs [17]. We have shown that JEV infection
can induce CFH expression in human and mouse micro-
glial cells and this induction is attenuated in miR-155
overexpressing cells. Therefore, it is possible that miR-155
expression in JEV-infected microglial cells inhibits CFH
expression, which in turn may benefit the host by facilitat-
ing complement activation against JEV.
In a study published earlier this month, Thounaojam
et al. [40] showed an up-regulation of miR-155 in mouse
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brain during JEV infection. They suggested that miR-155
had a pro-inflammatory role as its inhibition decreased
TBK-1, IRF3/7, and NF-κB phosphorylation both in BV-
2 cells as well as in the mouse brain. These results point
to a role for miR-155 that is opposite to what we have
observed in our study. A major difference between these
two studies is that while results reported by Thounaojam
et al. [40] are derived from mouse BV-2 cells and the
mouse brain where various different kinds of cells may
get infected with JEV, our results are derived entirely
from in vitro cultured human microglial cells CHME3.
Additionally, the GP78 strain of JEV used by Thounaojam
et al. [40] is a slow growing virus, both in cultured cells and
the mouse brain, with lesions in the virus-cell fusion
process [22]. Another reason for these differences may be
related to the smaller increase (approximately 4-fold) of
miR-155 during JEV infection in BV2 cells [40], compared
with the super maximal concentration in CHME3 cells
(approximately 100-fold) that occurred during miR-155
overexpression in the present study. Several reports have
suggested that, depending on the expression level, miR-155
can modulate cellular functions by targeting genes in differ-
ent pathways. Ceppi et al. [41] showed that low level
miR-155 expression enables the activation of p38 MAPK
pathway, favoring IL-1β expression, which induces inflam-
mation in an autocrine manner. However, the same path-
way was inhibited when the miR-155 expression level went
up significantly, ultimately reflecting an altered immune
profile. Similar observations were made by Xiao et al. [42]
who reported a 3-fold induction of miR-155 and pro-
inflammatory cytokine responses during Helicobacter pyl-
ori infection, whereas the overexpression of miR-155
negatively regulated the pro-inflammatory responses.
Intracellular signaling pathways that are concomi-
tantly activated by the same stimulus often interact
with one another through a cross regulatory feed-
back mechanism. The miR-155 is a multifunctional
microRNA and it can modulate inflammatory re-
sponses in both a positive and negative way [40-48].
Besides its positive role in NF-κB activation and
subsequent pro-inflammatory response, accumulating
evidence has demonstrated that it can constitute a
negative feedback loop in the NF-κB signaling
pathway by targeting multiple key proteins, which
ultimately leads to repression of, or at least the limi-
tation of NF-κB activation in response to viral or
microbial stimuli [41,42,45-48]. Therefore, miR-155
could modulate inflammation depending on various
factors including its expression level, the cell type,
and the environmental stimuli.
Overall our study suggests that miR-155 modulation
can act on multiple levels to control JEV infection of
microglial cells and induce innate immune responsesthat may be beneficial to the host. It can enhance CD45
expression, reduce pro-inflammatory cytokines and CFH
expression by targeting several key genes, and suppress
JEV replication in microglial cells. These data point to
miR-155 playing an important role in modulating JEV-
induced microglial activation that may be beneficial in
limiting JEV infection in the host. Additional studies,
both in vitro and in vivo, are needed to further under-
stand the role of miR-155 during JEV infection in
switching microglial activation towards the neuroprotec-
tive state.
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